There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Closed, Sticky:
New Resources for 1000 Genomes
|
35 responses
107,514 views
0 reactions
|
by laura
12-05-2013, 02:37 AM
|
||
|
Closed, Sticky:
Software packages for next gen sequence analysis
|
236 responses
683,808 views
1 reaction
|
by ECO
12-25-2009, 06:45 PM
|
||
|
4 responses
6,112 views
0 reactions
|
by GenoMax
04-11-2015, 01:54 PM
|
|||
|
5 responses
4,021 views
0 reactions
|
by GenoMax
04-11-2015, 03:50 AM
|
|||
|
2 responses
4,335 views
0 reactions
|
by Alun3.1
04-10-2015, 10:48 PM
|
|||
|
0 responses
1,011 views
0 reactions
|
by The_Learner
04-10-2015, 09:14 PM
|
|||
|
4 responses
10,608 views
0 reactions
|
by bpb9
04-10-2015, 07:44 AM
|
|||
|
1 response
1,889 views
0 reactions
|
by Michael Love
04-10-2015, 05:53 AM
|
|||
|
1 response
1,802 views
0 reactions
|
by diego diaz
04-10-2015, 05:15 AM
|
|||
|
3 responses
3,127 views
0 reactions
|
by GenoMax
04-10-2015, 04:06 AM
|
|||
|
0 responses
1,861 views
0 reactions
|
by KyuzoSeq
04-10-2015, 01:01 AM
|
|||
|
1 response
1,223 views
0 reactions
|
by Phoenix_ICE
04-10-2015, 12:49 AM
|
No topics found.
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.
-
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM -
Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.07-01-2026, 11:43 AM